IL157593A0 - Carbamate compounds for use in the treatment of pain - Google Patents

Carbamate compounds for use in the treatment of pain

Info

Publication number
IL157593A0
IL157593A0 IL15759302A IL15759302A IL157593A0 IL 157593 A0 IL157593 A0 IL 157593A0 IL 15759302 A IL15759302 A IL 15759302A IL 15759302 A IL15759302 A IL 15759302A IL 157593 A0 IL157593 A0 IL 157593A0
Authority
IL
Israel
Prior art keywords
pain
treatment
carbamate compounds
carbamate
compounds
Prior art date
Application number
IL15759302A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL157593A0 publication Critical patent/IL157593A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15759302A 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain IL157593A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
PCT/US2002/005421 WO2002067922A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number Publication Date
IL157593A0 true IL157593A0 (en) 2004-03-28

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15759302A IL157593A0 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Country Status (28)

Country Link
US (1) US6815464B2 (cs)
EP (1) EP1404312B1 (cs)
JP (1) JP4276838B2 (cs)
KR (1) KR100906315B1 (cs)
CN (1) CN1849116A (cs)
AR (1) AR033427A1 (cs)
AT (1) ATE493125T1 (cs)
AU (1) AU2002254015B2 (cs)
BR (1) BR0207673A (cs)
CA (1) CA2439274C (cs)
CY (1) CY1111349T1 (cs)
CZ (1) CZ20032298A3 (cs)
DE (1) DE60238765D1 (cs)
DK (1) DK1404312T3 (cs)
ES (1) ES2356617T3 (cs)
HU (1) HUP0303236A3 (cs)
IL (1) IL157593A0 (cs)
MX (1) MXPA03007721A (cs)
MY (1) MY129312A (cs)
NO (1) NO20033804L (cs)
NZ (1) NZ527994A (cs)
PL (1) PL364647A1 (cs)
PT (1) PT1404312E (cs)
RS (1) RS67603A (cs)
RU (1) RU2283106C2 (cs)
TW (1) TWI304735B (cs)
WO (1) WO2002067922A1 (cs)
ZA (1) ZA200307475B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL368164A1 (en) * 2001-07-16 2005-03-21 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2007230997A1 (en) * 2006-03-24 2007-10-04 Wyeth Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
EP2797880B1 (en) 2011-12-27 2017-03-01 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CA2267945C (en) * 1996-10-08 2005-05-17 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
PL364647A1 (en) 2004-12-13
KR20030076711A (ko) 2003-09-26
BR0207673A (pt) 2004-12-28
CY1111349T1 (el) 2015-08-05
HUP0303236A3 (en) 2012-07-30
MY129312A (en) 2007-03-30
AR033427A1 (es) 2003-12-17
ES2356617T3 (es) 2011-04-11
NO20033804D0 (no) 2003-08-26
DK1404312T3 (da) 2011-03-14
EP1404312B1 (en) 2010-12-29
RS67603A (sr) 2007-02-05
CZ20032298A3 (cs) 2004-08-18
WO2002067922A1 (en) 2002-09-06
JP2004523553A (ja) 2004-08-05
EP1404312A1 (en) 2004-04-07
DE60238765D1 (de) 2011-02-10
KR100906315B1 (ko) 2009-07-07
CA2439274C (en) 2011-04-05
AU2002254015B2 (en) 2006-08-24
PT1404312E (pt) 2011-02-01
RU2283106C2 (ru) 2006-09-10
ATE493125T1 (de) 2011-01-15
US6815464B2 (en) 2004-11-09
CN1849116A (zh) 2006-10-18
JP4276838B2 (ja) 2009-06-10
US20020156127A1 (en) 2002-10-24
NO20033804L (no) 2003-09-30
ZA200307475B (en) 2005-01-03
CA2439274A1 (en) 2002-09-06
MXPA03007721A (es) 2004-11-12
TWI304735B (en) 2009-01-01
NZ527994A (en) 2005-11-25
RU2003128984A (ru) 2005-03-20
HUP0303236A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL172418A0 (en) Therapeutic agents useful for treating pain
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL157593A0 (en) Carbamate compounds for use in the treatment of pain
GB0108671D0 (en) Skin treatment
GB0213869D0 (en) The treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB0211295D0 (en) Treatment of pain
GB0119025D0 (en) Compounds and their therapeutic use
IL164951A0 (en) The treatment of pain with lfendropil
GB0106316D0 (en) Apparatus for use in the treatment of hair
GB9904252D0 (en) Composition for the treatment of pain
HK1063015A (en) Carbamate compounds for use in the treatment of pain
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0211297D0 (en) Pain treatment
GB0325957D0 (en) The treatment of pain
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
GB0216978D0 (en) The treatment of pain
IL174968A0 (en) The use of ifenprodil in the treatment of pain
GB0322014D0 (en) The treatment of pain
GB0119173D0 (en) Pain treatment
GB0115489D0 (en) Pain treatment